BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27413548)

  • 1. The Need for Pediatric Formulations to Treat Children with HIV.
    Schlatter AF; Deathe AR; Vreeman RC
    AIDS Res Treat; 2016; 2016():1654938. PubMed ID: 27413548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral Therapy in Children and Adolescents: A Look Into Modern Single Tablet Regimens.
    Lee C; Sapasap J; LaRochelle J; Smith RO; Badowski ME
    J Pediatr Pharmacol Ther; 2021; 26(8):783-794. PubMed ID: 34790067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caretakers' barriers to pediatric antiretroviral therapy adherence in Vietnam - A qualitative and quantitative study.
    Tran CT; Pham TH; Tran KT; Nguyen TKC; Larsson M
    Appl Nurs Res; 2017 Jun; 35():1-5. PubMed ID: 28532715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral treatment in pediatric HIV infection in the United States: from clinical trials to clinical practice.
    Brogly S; Williams P; Seage GR; Oleske JM; Van Dyke R; McIntosh K;
    JAMA; 2005 May; 293(18):2213-20. PubMed ID: 15886376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with adherence to antiretroviral therapy among HIV infected children in Kabale district, Uganda: a cross sectional study.
    Wadunde I; Tuhebwe D; Ediau M; Okure G; Mpimbaza A; Wanyenze RK
    BMC Res Notes; 2018 Jul; 11(1):466. PubMed ID: 30001748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palatability, adherence and prescribing patterns of antiretroviral drugs for children with human immunodeficiency virus infection in Canada.
    Lin D; Seabrook JA; Matsui DM; King SM; Rieder MJ; Finkelstein Y
    Pharmacoepidemiol Drug Saf; 2011 Dec; 20(12):1246-52. PubMed ID: 21936016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers to optimal antiretroviral therapy adherence among HIV-infected formerly incarcerated individuals in New York City.
    Rowell-Cunsolo TL; Hu G
    PLoS One; 2020; 15(6):e0233842. PubMed ID: 32479552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with antiretroviral treatment interruption in human immunodeficiency virus (HIV)-1-infected children attending the Jos University Teaching Hospital, Jos, Nigeria.
    Ebonyi AO; Ejeliogu EU; Okpe SE; Shwe DD; Yiltok ES; Ochoga MO; Oguche S
    Niger Med J; 2015; 56(1):43-7. PubMed ID: 25657493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges and Opportunities in the Development of HIV Medications in Pediatric Patients.
    Dubrocq G; Rakhmanina N; Phelps BR
    Paediatr Drugs; 2017 Apr; 19(2):91-98. PubMed ID: 28074348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of protease inhibitor therapy in children with HIV infection.
    Gavin PJ; Yogev R
    Paediatr Drugs; 2002; 4(9):581-607. PubMed ID: 12175273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moving forward with treatment options for HIV-infected children.
    Beghin JC; Yombi JC; Ruelle J; Van der Linden D
    Expert Opin Pharmacother; 2018 Jan; 19(1):27-37. PubMed ID: 28879787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleoside and nucleotide reverse transcriptase inhibitors in children.
    Giaquinto C; Rampon O; Penazzato M; Fregonese F; De Rossi A; D'Elia R
    Clin Drug Investig; 2007; 27(8):509-31. PubMed ID: 17638393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Longitudinal Analysis of Daily Pill Burden and Likelihood of Optimal Adherence to Antiretroviral Therapy Among People Living With HIV Who Use Drugs.
    Mohd Salleh NA; Richardson L; Kerr T; Shoveller J; Montaner J; Kamarulzaman A; Milloy MJ
    J Addict Med; 2018; 12(4):308-314. PubMed ID: 29521670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to antiretroviral therapy and its determinants in children with HIV infection - Experience from Paediatric Centre of Excellence in HIV Care in North India.
    Seth A; Gupta R; Chandra J; Maheshwari A; Kumar P; Aneja S
    AIDS Care; 2014; 26(7):865-71. PubMed ID: 24266437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling HIV Pre-Exposure Prophylaxis.
    Straubinger T; Kay K; Bies R
    Front Pharmacol; 2019; 10():1514. PubMed ID: 32082142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update and review of antiretroviral therapy.
    Piacenti FJ
    Pharmacotherapy; 2006 Aug; 26(8):1111-33. PubMed ID: 16863488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamivudine monotherapy in children and adolescents: The devil is in the detail.
    Fairlie L; Bernheimer J; Sipambo N; Fick C; Kuhn L
    S Afr Med J; 2017 Nov; 107(12):1055-1057. PubMed ID: 29262955
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.